title: [New therapeutic choice for COPD: glycopyrronium bromide, a long-acting muscarinic antagonist].
authors.forename: Hajime
authors.initials: H
authors.lastname: Yoshisue
authors.forename: Masanari
authors.initials: M
authors.lastname: Kozawa
authors.forename: Maki
authors.initials: M
authors.lastname: Hiratsuka
authors.forename: Masaki
authors.initials: M
authors.lastname: Nakanishi
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D006024:Glycopyrrolate / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology; D006801:Humans; D018727:Muscarinic Antagonists / Q000008:administration & dosage / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology; D011485:Protein Binding; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*; D011976:Receptors, Muscarinic / Q000378:metabolism / Q000502:physiology
chemical_list: D003692:Delayed-Action Preparations; D018727:Muscarinic Antagonists; D011976:Receptors, Muscarinic; D006024:Glycopyrrolate